Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djae349 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Alan McWilliam und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Radiation Injuries, Prostatic Neoplasms, Radiotherapy. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Catalonia, NIHR, NIH HHS.
Abstract (Originalsprache)
Background
Overlapping genes are involved with rheumatoid arthritis (RA) and DNA repair pathways. Therefore, we hypothesized that patients with a high polygenic risk score for RA will have an increased risk of radiotherapy toxicity given the involvement of DNA repair.
Methods
Primary analysis was performed on 1494 prostate cancer, 483 lung cancer, and 1820 breast cancer patients assessed for development of radiotherapy toxicity in the REQUITE (validating pREdictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve QUalITy of lifE in cancer survivors) study. Validation cohorts were available from the Radiogenomics Consortium. All patients had undergone curative-intent radiotherapy and were assessed prospectively for toxicity. Germline genomic data was available for all patients, allowing a polygenic risk score to be calculated using 101 RA risk variants. Polygenic risk score was analyzed as a continuous variable and with a more than 90th percentile cutoff. Associations with acute and late standardized total average toxicity (STAT) scores and individual toxicity endpoints were analyzed in multivariable models with preselected adjustment variables.
Results
Increasing polygenic risk score for RA did not increase the risk of STAT-acute or STAT-late in any cohort. There was an increased risk of late esophagitis in the lung cancer cohort (coefficient = 0.018, P = .01), however this was not validated (P = .79). No individual acute or late toxicity endpoints were statistically significantly associated with polygenic risk score for the prostate or breast cohorts. No statistically significant results were found in the validation cohorts in multivariable models.
Conclusions
Patients with a high genetic risk for RA do not show increased levels of toxicity after radiotherapy suggesting treatment planning does not need to be modified for such patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
- The Christie NHS Foundation Trust, Manchester, United Kingdom.
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- Medical College of Wisconsin, Milwaukee, WI, United States.
- Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
ORCID-Profile: Alan McWilliam, Deborah Marshall, Sarah L Kerns, Gillian C Barnett, Ana Vega, Thodori Kapouranis, Miguel E Aguado Barrera, Barbara Avuzzi, David Azria, Jenny Chang-Claude, Alison Dunning, Corinne Faivre-Finn, Sara Gutiérrez-Enríquez, Olivia Fuentes-Ríos, Antonio Gómez Caamaño, Maarten Lambrecht, Carlos López Pleguezuelos, Tiziana Rancati, Tim Rattay, Petra Seibold, Elena Sperk, Christopher Talbot, Adam Webb, Liv Veldeman, Catharine M L West
Förderung
- Government of Catalonia
- NIHR
- NIH HHS
- Cancer Research Manchester Centre
- Generalitat de Catalunya for institutional
- Agencia Estatal de Investigación
- Vall d'Hebron Institute of Oncology
- Manchester Biomedical Research Centre
Zitieren
APA
McWilliam, A., Marshall, D., Kerns, S. L., Barnett, G. C., Vega, A., Kapouranis, T., Aguado Barrera, M. E., Avuzzi, B., Azria, D., Chang-Claude, J., Choudhury, A., Coedo Costa, C., Dunning, A., Farcy-Jacquet, M. P., Faivre-Finn, C., Gutiérrez-Enríquez, S., Fuentes-Ríos, O., Gómez Caamaño, A., Lambrecht, M., …, & REQUITE Consortium (2025). Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae349
Vancouver
McWilliam A, Marshall D, Kerns SL, Barnett GC, Vega A, Kapouranis T, et al. Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae349
BibTeX
@article{McWilliam2025,
author = {McWilliam, Alan and Marshall, Deborah and Kerns, Sarah L and Barnett, Gillian C and Vega, Ana and Kapouranis, Thodori and Aguado Barrera, Miguel E and Avuzzi, Barbara and Azria, David and Chang-Claude, Jenny and Choudhury, Ananya and Coedo Costa, Carla and Dunning, Alison and Farcy-Jacquet, Marie-Pierre and Faivre-Finn, Corinne and Gutiérrez-Enríquez, Sara and Fuentes-Ríos, Olivia and Gómez Caamaño, Antonio and Lambrecht, Maarten and López Pleguezuelos, Carlos and Rancati, Tiziana and Rattay, Tim and de Ruysscher, Dirk and Seibold, Petra and Sperk, Elena and Talbot, Christopher and Webb, Adam and Veldeman, Liv and Rosenstein, Barry S and West, Catharine M L and REQUITE Consortium, REQUITE Consortium},
title = {Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djae349}
}
EUVIMED